← Evidence map

ArticleMedical science monitor : international medical journal of experimental and clinical research2025

Optimizing Nivolumab Efficacy: The Role of Dosing Time in Advanced Non-Small Cell Lung Cancer.

Mustafa ErsoyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 41408743